Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anal Canal Carcinoma × Platinum × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 32 Uterine Cervical Neoplasms 18 Lung Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Small Cell Lung Carcinoma 16 Ovarian Neoplasms 12 Oropharyngeal Neoplasms 10 Urinary Bladder Neoplasms 9 Fallopian Tube Neoplasms 9 Carcinoma 9 Stomach Neoplasms 8 Mouth Neoplasms 8 Laryngeal Neoplasms 8 Hypopharyngeal Neoplasms 8 Breast Neoplasms 7 Nasopharyngeal Carcinoma 6 Mesothelioma, Malignant 6 Adenocarcinoma of Lung 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Medulloblastoma 5 Cholangiocarcinoma 5 Prostatic Neoplasms 4 Neuroblastoma 4 Ganglioneuroblastoma 4 Gallbladder Neoplasms 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Vulvar Neoplasms 3 Urethral Neoplasms 3

Interventions

Fluorouracil 8 Cisplatin 7 Radiotherapy 6 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Mitomycin 3 Capecitabine 3 dehydroftorafur 2 Radiation 2 Nivolumab 2 Cetuximab 2 Biopsy 2 toripalimab 1 pembrolizumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 Taxes 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Mitozytrex 1 Mitomycins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡